In addition, the increased lactic acid levels in the lung tumor microenvironment have been revealed to inhibit STING-dependent type-I IFN production in DCs, hampering the capacity of tumor-conditioned DCs to present tumor-associated antigens [194]. This evidence concerns the gene STING1 and neoplasm.